The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference78 articles.
1. COVID-19 pathophysiology: a review;Yuki;Clin Immunol,2020
2. The first 12 months of COVID-19: a timeline of immunological insights;Carvalho;Nat Rev Immunol,2021
3. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV;Ou;Nat Commun,2020
4. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein;Walls;Cell,2020
5. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection;Zou;Front Med,2020
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection;2024-08-21
2. Cytokine Signatures and Immune Dysregulation in COVID-19 Patients: Transcriptomic and Serum Analysis;Journal of Interferon & Cytokine Research;2024-08-01
3. Safety and efficacy of COVID-19 vaccination in the Chinese population with pulmonary lymphangioleiomyomatosis: a single-center retrospective study;Orphanet Journal of Rare Diseases;2024-07-03
4. Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic;Frontiers in Psychiatry;2024-06-24
5. Porcine TLR8 signaling and its anti-infection function are disturbed by immune checkpoint receptor TIM-3 via inhibition of P13K-AKT pathway;International Journal of Biological Macromolecules;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3